Coronavirus news highlights: Kerala reports 6,169 fresh Covid cases; Tamil Nadu sees 1,066
India records 23,950 new Covid-19 cases, 26,895 recoveries, and 333 deaths in the last 24 hours, as per Health Ministry. Two returnees from the United Kingdom tested positive for Covid-19 in Bengaluru on Tuesday and their samples are undergoing genomic testing to determine if they have contracted a new variant of the virus. Earlier, six passengers travelling on Air India's London-Delhi flight tested positive for Covid-19 on arrival in Delhi as several countries around the world banned flights and travellers from Britain. Meanwhile, Karnataka has imposed night curfew from 10 pm to 6 am starting today, till January 2. Stay tuned to DH for latest updates.
Thank you for following our coverage on the coronavirus crisis, to stay updated on the latest Covid-19-related news, click here.
22:2823 Dec 2020
People who are infected should also take Covid-19 vaccine: Bharat Biotech Chairman
Talking about the company's efficacy trials of its Covid-19 vaccine, he said that for the efficacy trials the company has taken 24 centres all over the country so that it has tier I ,tier II and tier III cities to capture the efficacy in a better way.
Centre starts contest for strengthening digital network platform 'CoWIN' for Covid-19 vaccine distribution
The government is enhancing use of the Electronic Vaccine Intelligence Network (eVIN) system, which provides real-time information on vaccine stocks and storage temperatures across all cold chain points in the country to address the needs for distribution and tracking of Covid-19 vaccine.
Covaxin's protection against Covid-19 could last 6 to 12 months, Phase-2 trials interim findings show
Researchers testing India's first indigenously developed vaccine candidate – BBV152, branded Covaxin - claimed that ithas displayed tolerable safety outcomes with enhanced humoral and cell-mediated immune responses in a wide age range ie., volunteers 12 years and above to 65 years and below.